---

Education:

• B.S. 1971 Pharmacy University of Wisconsin-Madison
• M.S. 1981 Radiopharmacy University of Southern California

Overview

Dick was the Director of Nuclear Pharmacy Services at the University of Wisconsin Hospitals for over 20 years. He received his B.S. in Pharmacy (1971) from the University of Wisconsin. After managing a clinic pharmacy for five years, he became the nuclear pharmacist at St. Luke's Hospital in Milwaukee. Hammes received his M.S. in Radiopharmacy (1981) from the University of Southern California and then practiced at the Madison VA Hospital and UW Hospitals and Clinics until his retirement in 2006.

In addition to his responsibility for the formal nuclear pharmacy courses, he has given many presentations to pharmacists, physicians, and technologists as an invited speaker and as an instructor in the U.W. Medical school residency programs. A member of APhA since 1972, he has been active in the nuclear section since 1977, serving as elected Chairman of the Nuclear Group in 1988-89 and again in 1994-95 when the group was reinstalled as the Section of Nuclear Pharmacy Practice within APPM. He passed the first nuclear pharmacy certification exam in 1982 and was recertified in 1991 and again in 1998. He was named a fellow of the APhA Academy of Pharmacy Practice and management in 1997. Dick is active in Kappa Psi Pharmaceutical Fraternity and has served as an officer of the Wisconsin Graduate Chapter since 1982, including 10 years as Regent. He is currently the faculty advisor for the undergraduate Kappa Psi Chapter. Other memberships have included the Society of Nuclear Medicine, ASHP, the Wisconsin Pharmacists Association, and Rho Chi.

He currently is working part time as the clinical nuclear pharmacist at the Covance Clinical Research Unit doing early studies for drug companies using Carbon-14 and Tritium radio-labeled tracers.

Work-Related Interests/Research:

Drug absorption, distribution, metabolism, excretion, and pharmacokinetic studies. Covance is a contract research company which does these studies on a contract basis for drug manufacturers.